Global Indemnity director granted 20,000 A-2 shares
McGeehan Thomas reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
McGeehan Thomas reported acquisition or exercise transactions in this Form 4 filing.
Global Indemnity Group, LLC director Thomas McGeehan received a grant of 20,000 Class A-2 Common Shares. The award was granted at no cash price as recognition for his services as a board member. According to the footnote, these A-2 shares vest only upon a Change of Control as defined in the award agreement.
After this grant, McGeehan directly holds 20,000 Class A-2 Common Shares and 78,851 Class A Common Shares. The filing reflects a compensation-related equity award rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A-2 Common Shares | 20,000 | $0.00 | $0.00 |
| Holding | Class A Common Shares | -- | -- | -- |
Footnotes (1)
- F1. Represents a grant of Class A-2 Common Shares ("A-2 Shares") awarded in recognition of services rendered as a board member of the Issuer. The A-2 Shares vest upon a Change of Control (as defined in the A-2 Shares Award Agreement).
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Global Indemnity Group (GBLI) director Thomas McGeehan report in this Form 4?
Does the Global Indemnity Form 4 show any stock sales by Thomas McGeehan?
AI-generated analysis. How Rhea-AI works. Not financial advice.